PTGS2 and neoplasm: ,62,63,64 Our pioneering exploration using AAV2-ABTB2 recombinants under the control of the tumor-specific promoter COX2 demonstrated its strong capacity for gene delivery and effective control of both mouse and human PDAC (Figure 7).